BMY vs DTIL · P/E 17, rev $24.46B vs rev $10.8M
Bristol-Myers Squibb Company (BMY) versus Precision BioSciences Inc (DTIL) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Christopher S. Boerner Ph.D..
Precision BioSciences Inc (DTIL) is a biotechnology company listed on US.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported DTIL revenue for 2026-06-30 was $10.8M. Net income was -$51.1M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. DTIL currently screens at market cap $48.1M.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. DTIL currently screens at market cap $48.1M.
Not investment advice. Open the BMY and DTIL stock pages for the full models.
Not investment advice.